A Study to Evaluate the Safety and Efficacy of VGB-R04 in Adult Hemophilia B Patients

NCT05441553 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia B

Interventions

GENETIC: VGB-R04

Sponsor

Shanghai Vitalgen BioPharma Co., Ltd.